Endo News Roundup: T1 and T2 Diabetes Management


Three studies show the potential of an artificial pancreas & a less invasive glucose testing device and a 2-drug combo to improve glycemic measures.

A hybrid closed-loop insulin delivery system, or so-called “artificial pancreas,” appears to be safe and effective in patients with T1DM. A novel flash glucose testing device can reduce the time adults with well-controlled T1DM spend in hypoglycemia. A combination of exenatide and dapagliflozin can improve glycemic measures and cardiovascular risk factors better than either drug alone in patients with T2DM inadequately controlled on metformin monotherapy.

Related Videos
Erin Michos, MD | Credit: Johns Hopkins University
Natalie McCormick, PhD | Credit: American College of Rheumatology
Medha Munshi, MD, (Courtesy: Harvard Health)
David Maahs, MD, PhD
Related Content
© 2023 MJH Life Sciences

All rights reserved.